2017
DOI: 10.1016/j.carbpol.2017.09.048
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of disulfide bond-conjugated LMWSC-g-bPEI as non-viral vector for low cytotoxicity and efficient gene delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(14 citation statements)
references
References 39 publications
0
14
0
Order By: Relevance
“…Under similar conditions, CS-BPEI copolymers were produced as non-viral gene carriers targeting chondrocytes and synoviocytes [ 59 ]. The conjugation of CS with BPEI-cystamine, in the presence of CDI, led to the formation of bioreducible copolymers for gene delivery [ 60 ]. While 1 H NMR analysis of the final system gave evidence for the combination of CS and BPEI, one cannot disregard that the copolymers were assembled by non-covalent interactions rather than bis-urea bonds due to the fast degradation of CDI in aqueous medium (see Section 5 for more details on the characterization of covalent CS-based copolymers).…”
Section: Strategies For Covalent Functionalizationmentioning
confidence: 99%
“…Under similar conditions, CS-BPEI copolymers were produced as non-viral gene carriers targeting chondrocytes and synoviocytes [ 59 ]. The conjugation of CS with BPEI-cystamine, in the presence of CDI, led to the formation of bioreducible copolymers for gene delivery [ 60 ]. While 1 H NMR analysis of the final system gave evidence for the combination of CS and BPEI, one cannot disregard that the copolymers were assembled by non-covalent interactions rather than bis-urea bonds due to the fast degradation of CDI in aqueous medium (see Section 5 for more details on the characterization of covalent CS-based copolymers).…”
Section: Strategies For Covalent Functionalizationmentioning
confidence: 99%
“…Furthermore, it is practically easy to create and chemically alter non-viral vectors on a large scale. Most importantly, the non-viral vector system is not restricted by the molecular size of the gene to be introduced [6,7,8].…”
Section: Introductionmentioning
confidence: 99%
“…Consequently, more and more scientists have turned their attention to the development of non-viral vectors and carriers [ 29 , 30 , 31 ]. Recent studies have shown that non-viral vectors have the following advantages: low immunogenicity, biodegradability, easy synthesis, low cost of production, and no restriction on the size of the molecules to be introduced [ 32 , 33 , 34 , 35 , 36 ]. The most extensively researched non-viral vectors are mainly polymers, liposomes, and nanoparticles [ 37 , 38 , 39 , 40 , 41 , 42 ].…”
Section: Introductionmentioning
confidence: 99%